The SMARTT cohort includes Human Immunodeficiency Virus (HIV) exposed but uninfected infants and children at 22 clinical sites in the United States of America across 13 states and territories namely Alabame, California, Colorado, Florida, Ilinois, Louisiana, Maryland, New Jersey, New York, Pennsylvania, Tennessee, Texas, and Puerto Rico. Study visits are conducted annually for 5 years and then every other year. The cohort also includes a comparison group of 239 HIV-unexposed and uninfected children of similar sociodemographic background enrolled at 1, 3, 5, or 9 years of age. These participants had a single evaluation and were not followed longitudinally.
Study design
Cohort - open, Cohort - primary caregiver and child
Number of participants at first data collection
9,060 (participants as of 2025)
Recruitment is ongoing
Age at first data collection
0 - 12 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2007
Primary Institutions
Harvard University (Academic, United States of America)
Profile paper DOI
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Government, United States of America)
National Heart, Lung, and Blood Institute (NHLBI) (Government, United States of America)
National Institute of Allergy and Infectious Diseases (NIAID) (Government, United States of America)
National Institute of Dental and Craniofacial Research (NIDCR) (Government, United States of America)
National Institute of Mental Health (NIMH) (Government, United States of America)
Ongoing?
Yes
Data types collected


Engagement
Keywords
Consortia and dataset groups